GENialOMICS

Weekly Group Assignments	Shared Group Journals	Project Links	Team Members
Week 10 Week 11 Week 12 Week 14 Week 15	GÉNialOMICS Week 10 GÉNialOMICS Week 11 GÉNialOMICS Week 12 GÉNialOMICS Week 14 GÉNialOMICS Week 15	GENialOMICS Home Page GENialOMICS Deliverables Gene Database Project Overview Instructions for Project Deliverables Project Manager Guild Page GenMAPP User Guild Page Quality Assurance Guild Page Coder Guild Page	Project Manager/Coder: Anu Varshneya Quality Assurance: Brandon Litvak GenMAPP User: Veronica Pacheco GenMAPP User: Kevin Wyllie

Week 10

• On November 3, 2015, GÉNialOMICS chose to create database for Burkholderia cenocepacia.
• On November 5, 2015, a journal detailing the complete genome of Burkholderia cenocepacia (strain J2315) titled The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients was found.

Weel 11

Weekly Goals and Progress
Anu Varshneya	Goals	Complete journal club individual assignment Create and practice journal club presentation with Brandon Find a MOD Create project timeline with soft deadlines for each person/milestone Complete milestone 0: Working Environment Setup Complete milestone 1: Version Control Setup Begin milestone 2: “Developer Rig” Setup and Initial As-Is Build Reformat Home Page with Dr. Dahlquists recommendations
	Progress	Found a possible model organism database (with Brandon Litvak)
Brandon Litvak	Goals
	Progress	Found a possible model organism database.
Veronica Pacheco	Goals	Work with Kevin Wyllie Understand experimental design Understand sample-data relationship raw.zip and .sdrf Construct sample-data diagram Develop compiled raw data file
	Progress
Kevin Wyllie	Goals	Work with Veronica Pacheco Understand experimental design Understand sample-data relationship raw.zip and .sdrf Construct sample-data diagram Develop compiled raw data file
	Progress

Other Progress:

• A journal using the B. cenocepacia genome in a microarray experiment titled Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species was approved for analysis.